Kolexia
Papeix Anne-Caroline
Neurologie
Fondation Adolphe de Rothschild
Paris, France
268 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérose en plaques Sclérose Neuromyélite optique Sclérose en plaques récurrente-rémittente Névrite optique Névrite COVID-19 Maladies démyélinisantes Myélite

Industries

Biogen
18 collaboration(s)
Dernière en 2023
Roche
12 collaboration(s)
Dernière en 2022
Alexion
11 collaboration(s)
Dernière en 2023
Merck-Serono
8 collaboration(s)
Dernière en 2021

Dernières activités

Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
JAMA neurology   12 février 2024
Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES): Evaluation of Biological Response to SARS-COV2 in Patients With Pre-existing Neurological Disease or With New Neurological Manifestations of COVID-19
Essai Clinique (Assistance publique – Hôpitaux de Paris)   01 février 2024
Real-life study to assess effectiveness and safety of eculizumab in patients with neuromyelitis optica spectrum disorders in France: protocol for ECUP4, an observational study.
Frontiers in neurology   22 janvier 2024
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
Multiple sclerosis (Houndmills, Basingstoke, England)   21 janvier 2024
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy.
Journal of neurology   11 janvier 2024
Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacks.
Annals of intensive care   08 janvier 2024
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder.
Neurology(R) neuroimmunology & neuroinflammation   22 décembre 2023
Prognosis of patients with multiple sclerosis associated with uveitis
Multiple sclerosis and related disorders   01 décembre 2023
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod.
Journal of neurology   01 novembre 2023
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial.
JAMA neurology   10 octobre 2023